Novo Nordisk A/S Common Stock (NVO)

Financing Cash Flow

-kr 24.19B

TTM · Period ending: · DKK

NVO logo

NVO Financing Cash Flow

Latest reported-kr 24.19B DKK
NVO TTM Cash from Financing · DKK (-kr 3.47B → -kr 24.19B)
High-resolution chart · PNG

NVO financing cash flow history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Financing Cash Flow — Trailing twelve months (TTM) (DKK)
Period endingFinancing Cash Flow (DKK)
-24,194,000,000
-51,292,000,000
-28,408,000,000
-21,040,000,000
-22,345,000,000
40,568,000,000
8,735,000,000
-38,216,000,000
-39,647,000,000
-68,919,000,000
-63,158,000,000
-60,710,000,000
-55,441,000,000
-53,283,000,000
-51,797,000,000
-39,580,000,000
-36,748,000,000
-30,153,000,000
-25,493,000,000
-30,402,000,000
-29,365,000,000
-33,210,000,000
-32,244,000,000
-37,085,000,000
-36,403,000,000
-35,468,000,000
-35,484,000,000
-34,435,000,000
-35,232,000,000
-33,909,000,000
-34,521,000,000
-34,971,000,000
-35,796,000,000
-36,101,000,000
-35,689,000,000
-35,182,000,000
-34,747,000,000
-35,438,000,000
-38,887,000,000
-39,239,000,000
-33,030,000,000
-32,911,000,000
-30,101,000,000
-29,526,000,000
-28,490,000,000
-27,721,000,000
-26,533,000,000
-25,680,000,000
-24,558,000,000
-25,956,000,000
-23,639,000,000
-22,328,000,000
-21,477,000,000
-20,429,000,000
-20,140,000,000
-21,391,000,000
-24,280,000,000
-20,384,000,000
-16,802,000,000
-15,342,000,000
-14,643,000,000
-14,668,000,000
-13,220,000,000
-13,251,000,000
-11,729,000,000
-11,097,000,000
-10,045,000,000
-9,733,162,450
-9,016,311,000
-8,508,851,350
-7,387,245,200
-8,269,039,950
-8,956,138,100
-8,099,315,410
-6,842,532,000
-4,659,485,770
-4,417,666,100
-4,583,483,990
-4,757,805,200
-5,110,312,070
-3,682,542,240
-4,905,226,940
-4,431,697,940
-4,799,462,970
-4,486,656,740
-3,785,772,860
-3,473,783,730
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.